Back to search

Article

Pharmacogenomics to Drive COVID-19 Therapy for Best Outcome in a Low Resource Setting

2020-09-02

Abstract excerpt

Corona virus disease 2019 (COVID-19) has taken the world by storm with global infectivity and mortality of 3.5%. Since there is no specific treatment for COVID-19, several drugs have been repurposed to combat infection, these include drugs like anti-malarial – chloroquine, hydroxychloroquine, anti- diarrheal– loperamide and antipsychotic-promazine, which have been considered to be effective inhibitors as of viral...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30ddc0f7-cbc2-55c7-9593-7f9855e87ae1
DOI
10.21467/preprints.214
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacogenomics to Drive COVID-19 Therapy for Best Outcome in a Low Resource SettingDOI 10.21467/preprints.214
Select a neighboring publication to make it the new centre.